Jane Chung - Aug 9, 2023 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Chief Commercial Officer
Signature
/s/ Edward C. Albini as attorney-in-fact for Jane Chung
Stock symbol
STRO
Transactions as of
Aug 9, 2023
Transactions value $
-$27,358
Form type
4
Date filed
8/11/2023, 04:16 PM
Previous filing
Jun 9, 2023
Next filing
Dec 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise $0 +18.8K +96.5% $0.00 38.2K Aug 9, 2023 Direct
transaction STRO Common Stock Tax liability -$27.4K -6.48K -16.98% $4.22 31.7K Aug 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -18.8K -33.33% $0.00 37.5K Aug 9, 2023 Common Stock 18.8K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F2 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total shares annually beginning on August 9, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.